Leflutrozole
Tier C — Watch / tradeLeflutrozole
Targets：Aromatase
Indications (approved)：Infertility, 男性不育症, 无精子症, 低促性腺激素性性腺功能减退, Hypogonadism, Endometriosis
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| LEFLU-001 | - | 4,4'-((1H-1,2,4-triazol-3-yl)methylene)dibenzonitrile |
| Leflutrozole | 143030-47-1 | 4,4'-(fluoro(1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile |
Frequently asked questions
What are the approved indications of Leflutrozole?
Approved indications include: Infertility, 男性不育症, 无精子症, 低促性腺激素性性腺功能减退, Hypogonadism, Endometriosis.
When does the Leflutrozole patent expire?
No public expiry year is available for Leflutrozole yet; this page updates once verified.
How many synthesis routes are recorded for Leflutrozole?
1 synthesis routes are recorded; the shortest is 1 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Leflutrozole intermediates?
All intermediates in Leflutrozole routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Leflutrozole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21